Stay updated with breaking news from Test Biotec. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec have announced Emergency Use...
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec today announced their newly...
/PRNewswire/ -- CerTest Biotec and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration...
Share this article Share this article ZARAGOZA, Spain and FRANKLIN LAKES, N.J., April 27, 2021 /PRNewswire/ -- CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the VIASURE SARS-CoV-2 (N1 + N2) Real Time PCR Detection Kit for the BD MAX™ Molecular Diagnostic System can now be run on saliva specimens. This allows BD MAX™ System users more flexibility with three alternatives for specimen collection: nasopharyngeal, oropharyngeal and saliva. This kit, CE marked to the IVD Directive (98/79/CE), detects all c...
BD, CerTest Biotec Say Their Real-time PCR Detection Kit Can Now Run On Saliva Specimens BD MAX System users now have three alternatives for specimen collection including nasopharyngeal, oropharyngeal and saliva. This CE marked kit detects all currently identified variants of SARS-CoV-2, the companies said. 'This new specimen type alternative for VIASURE SARS-CoV-2 (N1+N2) Real Time PCR Detection Kit for the BD MAXT System is complementing our versatile respiratory menu and is one step further in our goal to reach more patients with the right test and at the right time,' said Nikos Pavlidis, ...